Filter
467
Featured
24
88
Language
Document type
326
53
44
20
11
6
3
3
1
Countries
19
15
15
15
13
11
9
9
9
8
8
8
7
7
7
6
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
186
41
19
10
5
5
3
Toolboxes
176
32
30
24
8
7
7
3
2
2
2
2
2
1
1
1
1
Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-19, HIV và thuốc antiretrovirals (ARVs)
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
Supplement Article
Antiretrovirals to Prevent HIV Infection • CID 2015:60 (Suppl 3) • S159 - S160
HIV Treatment
Policy Brief
July 2017
Accessed 7 July 2015
HIV i-Base
July 2018
A treatment literacy guide for pregnant women and mothers living with HIV
Positive Health, Dignity and Prevention for Women and their Babies is intended for use by networks of women living with HIV, women’s groups, peer educators and others wishing to help guide women living with HIV t ...
Positive Health, Dignity and Prevention for Women and their Babies is intended for use by networks of women living with HIV, women’s groups, peer educators and others wishing to help guide women living with HIV t ...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
PLOS ONE | DOI:10.1371/journal.pone.0172392 February 16, 2017
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Technical Update
HIV Treatment
July 2017
Supplement Article
J Acquir Immune Defic Syndr Volume 75, Supplement 2, June 1, 2017 www.jaids.com
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
